By - press release
Category - Mobile ApplicationSource - http://www.marketwatch.com
 |
| Mobile Application |
INDIANAPOLIS, June 1, 2012 /PRNewswire via COMTEX/ --
Today, Eli Lilly and Company
LLY
-1.93%
launched a searchable clinical trial mobile application for oncology
healthcare professionals. The app - available for Apple iPad and iPhone,
as well as RIM's BlackBerry and Google's Android platforms - allows
healthcare professionals to search oncology trials that are enrolling
new patients by disease state, molecule being studied, study phase,
country, state and keyword.
Because the mobile app provides details on all global oncology trials,
the app's functionality also provides a mechanism for the healthcare
professional to contact Lilly Oncology for additional details on its
trials, as well as a third-party contact for the non-Lilly clinical
trials.
"Lilly Oncology created the Clinical Trial Resource mobile app to offer
cancer care professionals an easy way to search for and identify details
about all global oncology clinical trials - not just those sponsored by
Lilly," said Anne White, senior director of portfolio management with
Lilly Oncology. "The information will enable physicians to provide the
most current study information - quickly - to patients who may be
interested in participating in a clinical trial."
Clinical trial app available on new Lilly Oncology websiteDirections for
downloading the clinical trial app are available on a new website,
LillyOncologyPipeline.com, an online resource that will house
information on its pipeline of potential cancer and supportive care
molecules. At LillyOncologyPipeline.com, healthcare professionals can
search for information about Lilly Oncology's pipeline by drug discovery
platform, cancer type, clinical trial phase and molecular target.
Specific information about each medicine includes illustrations of the
target pathway and, when available, video of the pipeline compound's
method of action.
"With LillyOncologyPipeline.com, the healthcare professional will now
have immediate access to detailed information on our diverse oncology
pipeline," added White. "We hope that this will foster not only greater
awareness of our potential medicines, but also spark innovative
collaborations that ultimately change the world of cancer care."
Note: The safety and efficacy of the agents under investigation have not
been established. There is no guarantee that the agents will receive
regulatory approval and become commercially available for the uses being
investigated.
About Lilly OncologyFor more than four decades, Lilly Oncology, a
division of Eli Lilly and Company, has been dedicated to delivering
innovative solutions that improve the care of people living with cancer.
Because no two cancer patients are alike, Lilly Oncology is committed
to developing novel treatment approaches. To learn more about Lilly's
commitment to cancer, please visit
www.LillyOncology.com .
About Eli Lilly and CompanyLilly, a leading innovation-driven
corporation, is developing a growing portfolio of pharmaceutical
products by applying the latest research from its own worldwide
laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides
answers - through medicines and information - for some of the world's
most urgent medical needs.
P-LLY
This press release contains forward-looking statements about a
searchable clinical trial mobile application for oncology healthcare
professionals. It reflects Lilly's current beliefs; however, these
statements involve risks and uncertainties and actual results may
differ. For example, the application is dependent on third-party
content and there is no guarantee that the application will be utilized
as anticipated or provide the expected results. For further discussion
of risks and uncertainties, please see Lilly's latest Forms 10-Q and
10-K filed with the U.S. Securities and Exchange Commission. Lilly
undertakes no duty to update forward-looking statements.
Source - http://www.marketwatch.com/story/new-mobile-app-helps-doctors-find-clinical-trials-for-cancer-patients-2012-06-01
No comments:
Post a Comment